UK markets open in 1 hour 14 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,456.60 +249.47 (+1.37%) CRUDE OIL
79.22 +0.27 (+0.34%) GOLD FUTURES
2,316.20 +6.60 (+0.29%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,468.64 +1,819.46 (+3.99%)
Biomea Fusion, Inc. (BMEA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 11.57 |
| Open | 11.53 |
| Bid | 11.89 x 200 |
| Ask | 11.97 x 100 |
| Day's range | 11.40 - 12.07 |
| 52-week range | 8.12 - 43.69 |
| Volume | |
| Avg. volume | 1,032,891 |
| Market cap | 429.584M |
| Beta (5Y monthly) | -0.54 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
We're Keeping An Eye On Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Zacks
Biomea Fusion (BMEA) Stock Surges 41% in a Month: Here's Why
Biomea Fusion (BMEA) rises 41% in a month on the back of positive investor expectations regarding the clinical development of its lead candidate, BMF-219, for the type II diabetes indication.
- Zacks
Biomea (BMEA) Doses First Patient in Leukemia Study, Stock Up
Biomea (BMEA) successfully doses the first patient in its phase I study of BMF-500 to treat adult patients with acute leukemia. The company's stock rises 6.7% on the news.
© 2024 Yahoo. All rights reserved.